2014 Annual Meeting | 7HC.010 - Imaging and Genomics for Detecting Neurodegenerative Proteinopathy in Clinical Practice

Date Friday 05/02/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Tiffany W. Chow, MD, FAAN

Topic(s) General Neurology

Learning Objectives Participants should be able to understand the concept of personalized medicine and its role in neurodegenerative disease; understand types of biomarkers and their role in neurodegenerative disease; gain knowledge in the specific neuroimaging and genomic biomarker signatures of the major classes of neurodegenerative diseases; understand how the biomarkers can be used in conjunction with clinical findings to refine the differential diagnosis; and understand how the biomarkers may be used in the future to facilitate targeted therapies.

CME Available No CME available

Program Tracks Subspecialty in Focus

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:15 PM		Genomics in Neurodegenerative Disorders: An Overview Mario Masellis, MD
01:15 PM - 01:30 PM		Imaging Biomarkers in Lewy Body Spectrum Disorders Mario Masellis, MD
01:30 PM - 02:00 PM		Detecting Alpha-Synucleinopathy Martin Ingelsson, MD, PhD
02:00 PM - 02:30 PM		Imaging Biomarkers in Frontotemporal Degenerations Tiffany W. Chow, MD, FAAN
02:30 PM - 02:45 PM		Break
02:45 PM - 03:15 PM		Detecting Prion Disease and Infection Simon Mead
03:15 PM - 03:45 PM		Imaging Biomarkers in Amyloidopathy Mario Masellis, MD
03:45 PM - 04:15 PM		Detecting Proteinopathy in CSF and Plasma Yolande Pijnenburg
04:15 PM - 04:45 PM		Discussion
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Tiffany W. Chow, MD, FAAN	No disclosure on file
Mario Masellis, MD	Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. The institution of Dr. Masellis has received research support from Canadian Institutes of Health Research. The institution of Dr. Masellis has received research support from Ontario Brain Institute. The institution of Dr. Masellis has received research support from Weston Brain Institute. The institution of Dr. Masellis has received research support from Washington University. The institution of Dr. Masellis has received research support from Alector. Dr. Masellis has received publishing royalties from a publication relating to health care.
Simon Mead	No disclosure on file
Yolande Pijnenburg	No disclosure on file
Martin Ingelsson, MD, PhD	No disclosure on file